2 unknown, 1 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Completed 1 |
Follow Refractory Epilepsy: new trials by email Literature Review of Refractory Epilepsy trials Research Report on Refractory Epilepsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes Fenfluramine - Refractory Epilepsy, SYNGAP1 Encephalopathy | Phase 4 | Completed | Hospital Ruber Internacional | 20 | 2022-10-20 | 2026-09-29 |
| Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children RiTUXimab Injection [Rituxan] - Refractory Epilepsy | Phase 4 | Unknown | Assiut University | 140 | 2020-10-01 | 2020-09-09 |
| Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy clobazam (Onfi), Initial conversion and titration, Conversion schedule - Week 1 - Refractory Epilepsy | Phase 4 | Unknown | St. Joseph's Hospital and Medical Center, Phoenix | 21 | 2013-02-01 | 2017-03-03 |
Drug Resistant Epilepsy (3) · Epilepsy (2) · Brain Diseases (1) · Chromosome 15q, tetrasomy (1) · Epileptic Encephalopathy, Early Infantile, 4 (1) · Genetic Diseases, Inborn (1) · Nervous System Diseases (1)
Central Nervous System Diseases (3) · Brain Diseases (2) · Nervous System Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Epilepsy (1)
Adrenal Cortex Hormones (1) · Clobazam (1) · Diet, Ketogenic (1) · Fenfluramine (1) · Rituximab (1) · Trace Elements (1)
Assiut University (1) · Hospital Ruber Internacional (1) · St. Joseph's Hospital and Medical Center, Phoenix (1)
Spain (1) · United States (1)
Antonio Gil-Nagel, MD, PHD (1) · Steve Chung, MD (1)